Literature DB >> 6092687

Induction of antibody to foot-and-mouth disease virus in presensitized mouse spleen cell cultures.

T Collen, K C McCullough, T R Doel.   

Abstract

Cultures of spleen cells from immunized mice were stimulated in vitro by soluble preparations of purified foot-and-mouth disease virus. Virus-specific antibody, as detected by an enzyme-linked immunosorbent assay, was produced by immune spleen cells but not by normal, nonimmune cells. The optimal specific response was obtained with 1 microgram of virus per ml of culture; as the virus concentration was increased, the production of specific antibody was reduced. For very low concentrations of virus (less than 0.01 microgram per culture), there was tentative evidence of suppression of the specific antibody response. The levels of specific antibody induced were dependent on the source and number of plastic-adherent cells present in the cultures. We intend to use this model system to study further the basis of immunity to foot-and-mouth disease virus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092687      PMCID: PMC254569     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro.

Authors:  H Kirchner; G Tosato; R M Blaese; S Broder; I T Magrath
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

2.  Foot-and-mouth disease vaccine: influence of the vaccine virus subtype on neutralizing antibody and resistance to disease.

Authors:  J H Graves; P D McKercher; J J Callis
Journal:  Am J Vet Res       Date:  1972-04       Impact factor: 1.156

3.  Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

4.  Localization of human antigen-specific helper and suppressor function in distinct T-cell subpopulations.

Authors:  C J Heijnen; F UytdeHaag; F H Gmelig-Meyling; R E Ballieux
Journal:  Cell Immunol       Date:  1979-03-15       Impact factor: 4.868

5.  Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease.

Authors:  S M Golding; R S Hedger; P Talbot
Journal:  Res Vet Sci       Date:  1976-03       Impact factor: 2.534

6.  Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses.

Authors:  R C Knudsen; C M Groocock; A A Andersen
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

7.  Antibody response in vitro to an animal virus: production of rabies virus neutralizing antibodies by mouse cells in culture.

Authors:  H Koprowski; P Mocarelli; T J Wiktor
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

8.  In vitro induction and measurement of hemolytic plaque forming cells in man.

Authors:  H M Dosch; E W Gelfand
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Immunization of normal mouse spleen cell suspensions in vitro.

Authors:  R I Mishell; R W Dutton
Journal:  Science       Date:  1966-08-26       Impact factor: 47.728

10.  Induction of an antibody response in cultures of human peripheral blood lymphocytes.

Authors:  A L Luzzati; M J Taussig; T Meo; B Pernis
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  2 in total

1.  In vitro synthesis of foot-and-mouth disease virus specific antibodies by porcine leukocytes.

Authors:  A Rodríguez; J C Sáiz; F Sobrino
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Induction of immature dendritic cell apoptosis by foot and mouth disease virus is an integrin receptor mediated event before viral infection.

Authors:  Huali Jin; Chong Xiao; Gan Zhao; Xiaogang Du; Yang Yu; Youmin Kang; Bin Wang
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.